APLM
Apollomics Inc. Class A Ordinary Shares
$6.920+-0.000 (-0.000%)
Reaalajas hind
Hinnagraafik
Loading Chart...
Põhinäitajad
Turunäitajad
Avatud
$6.920
Kõrge
$6.920
Madal
$6.920
Maht
0.00M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
GlobeNewswire
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew interim data for
Vaata rohkem
GlobeNewswire
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung
Vaata rohkem
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.